The document provides the schedule for Monday, 24/Feb/2014 of the CardioEgypt 2014 conference. It lists the various sessions taking place across 5 halls (Rock Cany, Pearl I, Coral, Granite, Pearl II) from 11:30-13:00 and 13:00-14:30, covering topics like interventions, echo, acute cardiac care, pediatric cardiology, and heart rhythm. The schedule provides the session name, chairperson, speakers, speech titles and timings.
This document provides the schedule for the scientific program on Tuesday, June 2nd, 2015 of the CardioAlex conference. There are multiple sessions running concurrently throughout the day covering topics like electrophysiology, interventions, imaging, heart failure, hypertension, diabetes and more. The schedule lists the session themes, presenters, presentation titles and timings.
This document contains the schedule for the CardioEgypt 2022 conference taking place from February 21-25. It lists the various sessions on topics related to electrophysiology and pediatrics that will be presented each day. Presentations will cover case presentations, ablation techniques, imaging, device troubleshooting, pediatric interventions, debates and more. There will also be dedicated technical and nursing sessions covering topics such as infection control, anti-platelet therapy, CPR guidelines, pacing indications and coronary anomalies. The schedule provides timing, speaker names and titles for over 100 presentations across the 5 day conference program.
This document contains the schedule for a conference on cardiology that will take place from December 24-25, 2015. It lists the session titles, chairs, presenters and presentation times for various talks on topics such as new pacing technologies, atrial fibrillation management, cardiac resynchronization therapy, anticoagulation in special populations, ventricular arrhythmia ablation and lead extraction safety. The schedule indicates multiple sessions will occur simultaneously in the main conference hall over the two day period.
This document provides best practices for writing successful direct mail. It recommends focusing on the audience and objectives, using short words, sentences and paragraphs, and repeating the call to action multiple times. Key messages should be supported with benefits, specifics, testimonials and visuals like charts. Direct mail should be signed by a person, link to digital assets, and be tested. Resources for writers include a white paper, online calculator, video and eBook. The document emphasizes writing for scanners, using numbers strategically, selling benefits over features, and teaming with designers.
This document provides the schedule for the scientific program on Tuesday, June 2nd, 2015 of the CardioAlex conference. There are multiple sessions running concurrently throughout the day covering topics like electrophysiology, interventions, imaging, heart failure, hypertension, diabetes and more. The schedule lists the session themes, presenters, presentation titles and timings.
This document contains the schedule for the CardioEgypt 2022 conference taking place from February 21-25. It lists the various sessions on topics related to electrophysiology and pediatrics that will be presented each day. Presentations will cover case presentations, ablation techniques, imaging, device troubleshooting, pediatric interventions, debates and more. There will also be dedicated technical and nursing sessions covering topics such as infection control, anti-platelet therapy, CPR guidelines, pacing indications and coronary anomalies. The schedule provides timing, speaker names and titles for over 100 presentations across the 5 day conference program.
This document contains the schedule for a conference on cardiology that will take place from December 24-25, 2015. It lists the session titles, chairs, presenters and presentation times for various talks on topics such as new pacing technologies, atrial fibrillation management, cardiac resynchronization therapy, anticoagulation in special populations, ventricular arrhythmia ablation and lead extraction safety. The schedule indicates multiple sessions will occur simultaneously in the main conference hall over the two day period.
This document provides best practices for writing successful direct mail. It recommends focusing on the audience and objectives, using short words, sentences and paragraphs, and repeating the call to action multiple times. Key messages should be supported with benefits, specifics, testimonials and visuals like charts. Direct mail should be signed by a person, link to digital assets, and be tested. Resources for writers include a white paper, online calculator, video and eBook. The document emphasizes writing for scanners, using numbers strategically, selling benefits over features, and teaming with designers.
Este documento proporciona consejos sobre las tres fases de una entrevista de trabajo: antes, durante y después. Antes de la entrevista, se recomienda investigar sobre la empresa y prepararse vistiéndose de manera apropiada y discreta. Durante la entrevista, se debe saludar de manera firme, escuchar activamente, mantener el contacto visual y responder con seguridad, entre otras cosas. Después de la entrevista, se aconseja evaluar el propio desempeño para identificar áreas de mejora.
The Affordable Care Act is a comprehensive health reform law that was passed in 2010. It expands access to health insurance coverage through Medicaid expansion, health insurance exchanges, and prohibiting denial of coverage for pre-existing conditions. It also enhances Medicare benefits, provides consumer protections, and focuses on prevention, wellness, and public health. The law aims to increase the number of Americans with health insurance and decrease the cost of health care.
This document discusses museums and their role in visitor experiences. It examines who typically visits museums and how museums can create new spaces and keep their collections fresh and relevant. It explores how museums can support visitors through their exhibitions, by making the experience engaging and memorable. Museums aim to meet visitor needs and make learning fun, while helping people understand exhibits and feel welcome. The role of digital technology and immersive experiences is also discussed.
The document contains the schedule for an intervention conference on Wednesday, October 7th, 2020.
The schedule includes sessions on ACS-MVL Disease Fireworks I and II from 12:30-13:30 and 13:30-14:30 in the Arena hall, discussing complete revascularization and individual patient case presentations.
A session on Thrombosis from 13:30-14:30 in the Small Theater will involve case discussions on anticoagulation in patients with renal insufficiency and detecting atrial fibrillation.
Additional sessions are scheduled throughout the day on various intervention and cardiology topics, including CTO fireworks, structural heart disease, endovascular procedures, complex cases
Este documento proporciona consejos sobre las tres fases de una entrevista de trabajo: antes, durante y después. Antes de la entrevista, se recomienda investigar sobre la empresa y prepararse vistiéndose de manera apropiada y discreta. Durante la entrevista, se debe saludar de manera firme, escuchar activamente, mantener el contacto visual y responder con seguridad, entre otras cosas. Después de la entrevista, se aconseja evaluar el propio desempeño para identificar áreas de mejora.
The Affordable Care Act is a comprehensive health reform law that was passed in 2010. It expands access to health insurance coverage through Medicaid expansion, health insurance exchanges, and prohibiting denial of coverage for pre-existing conditions. It also enhances Medicare benefits, provides consumer protections, and focuses on prevention, wellness, and public health. The law aims to increase the number of Americans with health insurance and decrease the cost of health care.
This document discusses museums and their role in visitor experiences. It examines who typically visits museums and how museums can create new spaces and keep their collections fresh and relevant. It explores how museums can support visitors through their exhibitions, by making the experience engaging and memorable. Museums aim to meet visitor needs and make learning fun, while helping people understand exhibits and feel welcome. The role of digital technology and immersive experiences is also discussed.
The document contains the schedule for an intervention conference on Wednesday, October 7th, 2020.
The schedule includes sessions on ACS-MVL Disease Fireworks I and II from 12:30-13:30 and 13:30-14:30 in the Arena hall, discussing complete revascularization and individual patient case presentations.
A session on Thrombosis from 13:30-14:30 in the Small Theater will involve case discussions on anticoagulation in patients with renal insufficiency and detecting atrial fibrillation.
Additional sessions are scheduled throughout the day on various intervention and cardiology topics, including CTO fireworks, structural heart disease, endovascular procedures, complex cases
This document contains the schedule for a two-day learning session on heart failure. It lists 18 sessions over the two days, each with a chairperson and 2-4 presentations on topics related to heart failure. Presentation topics include endothelial dysfunction, cardiac imaging, diabetes and heart disease, drug and device therapy, cardiomyopathy, clinical trials, and guidelines. It also includes interactive case presentations, hot topic discussions, and symposiums with experts.
This document provides an agenda for a pediatric cardiology conference taking place from 10:30 AM to 12:00 PM. It lists the chairpersons, moderator, and various presentations on topics related to pediatric cardiology such as pediatric isomerism, anomalous systemic venous drainage, diagnosing abnormalities via echocardiography, and the surgeon's perspective. Presentations range from 10 to 20 minutes with discussions scheduled after each.
This document provides an overview of the schedule for various sessions taking place on Tuesday, May 31st, 2016 at the conference. There are multiple sessions running concurrently between 11:00-12:00 and 12:30-13:30 on topics related to heart failure, imaging, intervention, electrophysiology, surgery, pediatrics and more. The schedule also lists various workshops, lectures and presentations happening between 13:30-14:30 and 14:30-15:30 on topics such as hypertension management, live transmissions, echocardiography and meetings with experts.
The document appears to be a schedule for the Egyptian Society of Cardiology annual conference. It lists the various sessions, lectures, and workshops taking place across multiple halls over the course of one or more days. Key details include sessions on pediatric cardiology, cardiac imaging, interventions for acute coronary syndrome, cardiac surgery, thrombosis, and keynote lectures. Teams of technicians and nurses are also participating in training sessions.
This document contains the schedule for the CardioAlex 2016 conference taking place from May 31st to June 3rd. It lists the various sessions, topics, speakers and locations. Some of the session topics include atrial fibrillation management, pacemakers in pediatric groups, the future of electrophysiology, cardiac anatomy and hands-on CPR training. The document provides an itinerary of presentations, debates and discussions around the latest research and guidelines in cardiac electrophysiology and resuscitation.
The document provides an agenda for the Rare Cardiomyopathies session taking place from 11:00-12:00 in Delegate Hall. It lists the chairpersons and presentations in order, including topics like Arrhythmogenic right ventricular dysplasia, Left ventricular non-compaction cardiomyopathies, Pacing-induced cardiomyopathy, and Peripartum cardiomyopathy. Each presentation is scheduled for 15 minutes including discussion.
The document outlines the schedule for an electrophysiology conference taking place from October 7-9, 2020. It includes sessions on game-changing electrophysiology trials focusing on various areas like CRT, AF ablation, and VT ablation. There will also be workshops on performing PVI using different energy sources such as cryoballoon and radiofrequency ablation. Additional sessions will cover challenging electrophysiology cases and debates around topics like pacing in heart failure and recurrent neurocardiogenic syncope.
This document provides a prefinal program for the CardioEgypt 2019 conference, which will take place from February 25-26, 2019. The program lists various sessions occurring each day, including state of the art lectures, interventions, imaging, general cardiology, congenital heart diseases, electrophysiology, and joint sessions. Presentations will cover topics like the management of syncope, cardiovascular imaging, building systems for STEMI care, controversies in hypertension, assessment of forgotten cardiac structures, sudden cardiac death, left main interventions, advanced heart failure, and cardiac stress imaging. The program notes that comments on the prefinal program will be considered within 24 hours.
The document outlines the schedule and program for the CardioEgypt 2015 conference taking place on February 23rd. The day includes plenary lectures on topics like Egypt's future and the causes of atherosclerosis. An opening ceremony will be held with speakers including the conference president and health minister. Two concurrent sessions are scheduled on functional flow reserve and recent advances in echocardiography. The FFR session will discuss artifacts, trials, use in ACS and differences between FFR and IFR. The echocardiography session will cover topics like 3D TEE, its role in percutaneous devices and TAVI procedures, and contrast echo in daily practice.
Similar to Cardio egypt 2014 full program copied by samir rafla (11)
This document discusses why every girl is a princess through her relationship with Jesus Christ. It provides six reasons:
1. As daughters of the King (Jesus), girls have inherent worth and should behave as princesses.
2. As ambassadors of Jesus, girls represent him through their conduct and behavior.
3. As servants of Jesus, girls should seek to help others in need on his behalf.
4. Jesus dwells within girls, so they can communicate with him intimately through prayer.
5. Jesus accepts friendship with people and is described as a friend in the Bible.
6. Girls are precious copies of Jesus, with people seeing him through their faces, speech and
This document summarizes recent advances in electrophysiology technologies:
1. New devices include dual chamber leadless pacemakers and a multi-electrode balloon catheter for radiofrequency ablation.
2. Subcutaneous ICDs eliminate transvenous leads, and a leadless CRT system is in development.
3. Improved ablation technologies include laser and radiofrequency balloon catheters.
4. Wearable and implantable devices are replacing Holter monitors for arrhythmia detection.
5. New electroanatomical mapping systems provide higher resolution maps.
6. MRI and ultrasound guidance are being used to visualize ablation effects.
7. Smartwatches can detect atrial fibrillation with E
1) Sudden cardiac death is a major public health problem, causing hundreds of thousands of deaths in the US each year. The most common causes are coronary artery disease and structural heart diseases.
2) Early recognition of SCD and initiation of cardiopulmonary resuscitation significantly improves chances of survival. Defibrillation within 5 minutes of cardiac arrest from ventricular fibrillation is critical.
3) New guidelines emphasize the importance of continuous chest compressions, use of automated external defibrillators, capnography to monitor CPR quality, and therapeutic hypothermia after resuscitation from cardiac arrest.
The document discusses junctional rhythms and disturbances. It describes how junctional rhythms can occur when retrograde conduction is impaired, resulting in AV dissociation with the ventricular rate usually faster than the atrial rate. An accelerated junctional rhythm is seen in patients with heart disease and is commonly caused by digitalis intoxication, acute myocardial infarction, surgery, or myocarditis. Occasionally, there can be exit block of the junctional impulse, slowing the ventricular rate. Junctional rhythms are evaluated based on the relationship between P waves and QRS complexes.
A beautiful paper published by Eugene Braunwald
European Heart Journal, Volume 42, Issue 24, 21 June 2021, Pages 2327–2328, https://doi.org/10.1093/eurheartj/ehab264
The document provides the 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation (AF) developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). It was created by the AF Task Force of the ESC with contributions from the EHRA. The Task Force included experts from various European countries who provided recommendations for the definition of AF, screening, diagnosis, assessment, and integrated management of AF patients. The guidelines represent an update based on recent clinical evidence and aim to improve diagnosis and optimize treatment strategies for AF.
The document is titled "Cardio Alex 2021 Electrophysiology Program" and was uploaded by Samir Rafla. It appears to be information about an electrophysiology program for the year 2021, though no other details are provided in the short title and uploader information given.
God created the heavens and the earth. Initially, the earth was formless and empty with darkness covering the deep. However, the Spirit of God was hovering over the waters. God then spoke light into existence and separated it from the darkness. He called the light "day" and the darkness "night," marking the first day. On the second day, God created an expanse to separate the waters above from the waters below, calling it the "sky."
This document contains the text of the Gospel of John from the Holy Bible. It recounts the works and teachings of Jesus Christ according to the Apostle John. Over 21 chapters, it describes Jesus turning water into wine at a wedding in Cana, cleansing the temple in Jerusalem, conversing with Nicodemus about being born again, speaking with a Samaritan woman at a well, performing miracles such as healing a royal official's son, teaching crowds about being the bread of life, and appearing after his resurrection to his disciples. The Gospel emphasizes Jesus' divine nature and mission to bring salvation and eternal life.
This document is the Gospel of Luke chapters 1-2 from the Holy Bible. It describes the birth and early life of Jesus Christ. In chapter 1, it describes Jesus' conception and the births of John the Baptist and Jesus. Zacharias and Elizabeth conceive John the Baptist, while Mary conceives Jesus after being visited by the angel Gabriel. In chapter 2, it describes Jesus' birth in Bethlehem and presentation at the Temple, as well as his childhood years growing up in Nazareth.
This summary provides the key details from the document in 3 sentences:
The document describes Jesus beginning his ministry by being baptized by John the Baptist. Jesus calls his first disciples and teaches with authority in the synagogues. Jesus heals many who are sick or possessed by demons, and teaches the crowds using parables about the kingdom of God.
The document provides background on the four Gospels of the New Testament - Matthew, Mark, Luke, and John. Though each Gospel was written separately, they all aim to convey God's favor toward humanity through Jesus Christ. The document then focuses on an overview of the Gospel of Matthew, summarizing each chapter in a few sentences to preview the key events and teachings contained therein, such as Jesus' birth, baptism, temptation, and beginning of his ministry.
This document provides information on valvular heart disease, focusing on mitral stenosis and mitral regurgitation. It discusses the etiology, pathophysiology, symptoms, physical exam findings, diagnostic testing, and treatment recommendations for each condition. Mitral stenosis is typically caused by rheumatic fever and leads to pulmonary hypertension from elevated left atrial pressures. Mitral regurgitation can result from several causes including rheumatic heart disease, papillary muscle dysfunction, and mitral valve prolapse. Physical exam findings help distinguish the murmurs associated with each condition. Echocardiography is important for diagnosis and determining treatment approach.
The document discusses approaches to treating different types of ventricular arrhythmias that can occur after a myocardial infarction, including conservative management of premature ventricular contractions, use of antiarrhythmic drugs like lidocaine and amiodarone for ventricular fibrillation and tachycardia, and recognizing reperfusion arrhythmias that may not require treatment. It also provides recommendations for evaluating patients at higher risk of arrhythmias and managing electrical storm through correcting underlying issues, antiarrhythmic drugs, and device programming.
This document summarizes the diagnosis, management, and treatment of COVID-19 infection. It describes the clinical symptoms and stages of the disease from mild to severe. Laboratory findings associated with different stages are provided. The principles of treatment include antiviral drugs, immunomodulators, corticosteroids, and other supportive care. Cardiovascular complications are common and include myocarditis, acute myocardial infarction, and heart failure. One case study describes a patient presenting with fulminant myocarditis and cardiogenic shock due to coronavirus infection who was successfully treated with medications to suppress inflammation, regulate the immune system, and support heart function.
1. Atrial fibrillation (AF) is classified based on duration and presence of symptoms, including first diagnosed, paroxysmal (<7 days), persistent (≥7 days), long-standing persistent (≥12 months), and permanent.
2. Risk factors for incident AF include structural heart disease, hypertension, obesity, smoking, diabetes, and age.
3. Treatment recommendations include long-term antiarrhythmic drugs like amiodarone, dronedarone, and flecainide/propafenone based on patient characteristics, as well as cardioversion and catheter ablation.
This document provides an overview of pacemakers and implantable cardioverter defibrillators (ICDs). It discusses the different types of pacemakers including single-chamber pacemakers (VVI), dual-chamber pacemakers (DDD), and biventricular pacemakers (CRT). It outlines the indications for pacemaker and ICD implantation and reviews potential complications of the procedures such as infection, lead issues, and pacemaker syndrome. Guidelines for device implantation and management are summarized including recommendations on timing after heart events, upgrades, and device selection. Risks associated with dual chamber devices are also mentioned.
This document provides guidelines for the diagnosis and treatment of heart failure, including recommendations on tests such as transthoracic echocardiography, brain natriuretic peptide levels, and cardiac imaging. It discusses the types of heart failure with preserved or reduced ejection fraction. The guidelines also cover medical therapies like angiotensin converting enzyme inhibitors, mineralocorticoid antagonists, angiotensin receptor neprilysin inhibitors, and devices for cardiac resynchronization or left ventricular assistance. Optimum medical therapy is emphasized.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
Executive Directors Chat Leveraging AI for Diversity, Equity, and InclusionTechSoup
Let’s explore the intersection of technology and equity in the final session of our DEI series. Discover how AI tools, like ChatGPT, can be used to support and enhance your nonprofit's DEI initiatives. Participants will gain insights into practical AI applications and get tips for leveraging technology to advance their DEI goals.
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
7. Monday, 24/Feb/2014
13:00
14:30
Hall:
Pearl II
Heart Rhythm
ECRA-8
Mini ECRA 2
Gamal Shaaban
Ossama Diab
Reda Diab
13:00 - 13:15
Ahmed El-Damaty
John Kamel
Chairperson
Sherif Hamed
Pre-excitation
Ghaliah Al-Mohany
13:15 - 13:20
Discussion
13:20 - 13:35
Egypt
Pacemaker types and indications
Ayman Morttada
Cairo
13:35 - 13:40
Discussion
13:40 - 13:55
Pacemaker programming and follow up
Ahmed Nabil
13:55 - 14:00
Discussion
14:00 - 14:15
Ain Shams
Pacemaker malfunction
Abdo El-Azab
14:15 - 14:20
Discussion
Cairo
8. Monday, 24/Feb/2014
13:00
14:30
Hall:
Coral
Acute Cardiac Care
ACC-9
ACCC 2
Resuscitation Science in 2014 – CPR
Faten Farid
Mohamed Selim
Sherif Mokhtar
13:00 - 13:15
Ahmed Ghali
Mohamed Helmy
Chairperson
Walid Hammady
The ABC of Basic Life Support in Acute
Cardiovascular Care
Hany El-Shahidy
13:15 - 13:18
Discussion
13:18 - 13:33
NHI
Guidelines for CPR, what is new?
Nesrine El-Rifaie
Cairo
13:33 - 13:36
Discussion
13:36 - 13:51
How long should we continue resuscitation efforts?
Randa Zein El-Din
13:51 - 13:54
Discussion
13:54 - 14:09
NHI
CPR in special situations
Yasser Yazid
14:09 - 14:12
Discussion
14:12 - 14:25
Cairo
CPR in Egypt; status in 2014
Hisham Salah
14:25 - 14:28
Discussion
Cairo
9. Monday, 24/Feb/2014
13:00
14:30
Hall:
Granite
Pediatric Cardiology
Ped-10
Ped 2
Pediatric Echo Workshop
Ahmed Abdel Moneim
Ahmed Meawad
Howaida El-Said
Chairperson
Nader Botros
Sameh Arab
13:00 - 13:20
Role of TEE in the diagnosis of CHD
Azza El-Fikky
13:20 - 13:25
Discussion
13:25 - 13:45
Ain Shams
3D Echo in CHD
Alaa Roshdy
13:45 - 13:50
Discussion
Ain Shams
11. Monday, 24/Feb/2014
15:00
17:00
Hall:
Blue Cany
Interventions
IHD-11
IHD 3
EAZI in CardioEgypt “C”
Ahmed Shawky
Hany Ragy
Mohamed Farid El-Gendy
IHD 3Chairperson
Sameh Sabet
Sherif El-Tobgy
15:00 - 15:25
Implementation of high sensitive cTnT in the
hospital's emergency departments “Sponsored by
Roche”
Evangelos Giannitsis
Germany
15:25 - 15:28
Discussion
15:28 - 15:47
10 points to remember in primary PCI
Ahmed Magdy
15:47 - 15:50
Discussion
15:50 - 16:10
NHI
LM PCI; learn from the expert
Pablo Avanzas
16:10 - 16:13
Discussion
16:13 - 16:33
Spain
An introduction to IVUS
Sayed Abdo
16:33 - 16:36
Discussion
16:36 - 16:56
KSA
Contrast Nephropathy
Ashraf Ahmed
16:56 - 17:00
Discussion
NHI
12. Monday, 24/Feb/2014
15:00
16:30
Hall:
Pearl I
Echo
Echo-12
Echo 3
Echo Summit
Ghada Kazamel
Marwa Mesheal
Mohamed Ossama
15:00 - 15:20
Gamela Nasr
Hany Fouad
Echo 3Chairperson
Sameh Bakhoum
Prosthetic Valves
Tarek Aziz
15:20 - 15:25
Discussion
15:25 - 15:45
NHI
Introduction to TEE
Wael Abdel Aal
15:45 - 15:50
Discussion
15:50 - 16:10
Cairo
Introduction to DSE
Walaa Adel
16:10 - 16:15
Discussion
Ain Shams
13. Monday, 24/Feb/2014
15:00
17:00
Hall:
Pearl I
Heart Rhythm
ECRA-13
Mini ECRA 3
Amir Abdel Wahab
Hayam El-Damanhoury
Ossama Diab
Mini EChairperson
Said Khaled
Sherif El-Degwy
15:00 - 15:15
EPS made easy
Sherif Hamed
15:15 - 15:20
Discussion
15:20 - 15:35
Cairo
Assessment of Syncope
Hisham Seif
Zagazig
15:35 - 15:40
Discussion
15:40 - 15:55
What the cardiologist need to know about CRT?
Mervat Aboul Maaty
Ain Shams
15:55 - 16:00
Discussion
16:00 - 16:15
What the cardiologist need to know about ICD?
Mazen Tawfik
16:15 - 16:20
Discussion
Ain Shams
14. Monday, 24/Feb/2014
15:00
16:00
Hall:
Granite
Pediatric Cardiology
Ped-15
Ped 3
Pediatric Echo Workshop
Alaa Roshdy
Hebatallah Attia
Howaida El-Said
Ped Chairperson
Magdy Aboul Kheir
Mohamed El-Tahlawy
15:00 - 15:20
Fetal echo, indications and limitations
Ahmed Abdel Moneim
Banha
15:20 - 15:25
Discussion
15:25 - 15:45
Role of fetal echo in the diagnosis of fetal arrhythmias
Suzan Bayoumy
15:45 - 15:50
Discussion
Tanta
15. Tuesday, 25/Feb/2014
8:30
10:00
Hall:
Blue Cany
Interventions
IHD-16
IHD
4
Worst Complications & Best Saves “Case Based”
Ahmed Magdy
Amr Hassan
Hisham Boshra
Chairperson
Khaled Shoukry
Mohamed El-Setiha
8:30 - 8:42
Perforation
Ahmed Sabry
8:42 - 8:45
Discussion
8:45 - 8:57
Kobry El Kobba
Radial complications
Mohamed Mandour
8:57 - 9:00
Discussion
9:00 - 9:12
NHI
Case Presentation
Ahmed Khashaba
9:12 - 9:15
Discussion
9:15 - 9:27
Ain Shams
Case Presentation
Walid Ammar
9:27 - 9:30
Discussion
9:30 - 9:42
Cairo
No reflow
Neeraj Jolly
9:42 - 9:45
Discussion
9:45 - 9:57
Case Presentation
9:57 - 10:00
Discussion
USA
16. Tuesday, 25/Feb/2014
8:30
10:00
Hall:
Rock Cany
Interventions
IHD-17
IHD 5
Latest clinical Trials; what did we learn ?
8:40 - 8:43
8:43 - 8:53
8:53 - 8:56
8:56 - 9:06
9:06 - 9:09
9:09 - 9:19
9:19 - 9:22
9:22 - 9:32
9:32 - 9:35
9:35 - 9:45
9:45 - 9:48
9:48 - 9:58
9:58 - 10:00
Ezz El-Din El-Sawy
Mohamed Ashraf
Mohamed Farid El-Gendy
8:30 - 8:40
Adel Zaki
Khairy Abdel Dayem
Chairperson
Moustafa El-Sayed
SYNTAX: five year results
El-Sayed Farag
Zagazig
Discussion
FREEDOM
Hossam El-Hossary
Cairo
Discussion
FAME II
Ayman Khairy
Assiut
Discussion
FIRST
Sherif Wagdy Ayad
Alexandria
Discussion
ARCTIC: Assessment by a double Randomization of a
Conventional antiplatelet strategy versus a
monitoring-guided strategy for drug-eluting stent
implantation and, of Treatment Interruption versus
Continuation 1 year after stenting
Ali Zidan
Alexandria
Discussion
PRAMI
Ahmed Yehia A.Samad
Al Azhar
Discussion
Hypothermia for STEMI: is there a role?
Mohamed Abdel Ghani
Cairo
Discussion
17. Tuesday, 25/Feb/2014
8:30
10:00
Hall:
Pearl I
Imaging
IMG-18
IMG 1
Cardiac Imaging Guiding Therapy
Ahmed Magdy Moustafa
Ali El-Amin
Ashraf El-Amir
8:30 - 8:45
Adel Youssef
Ahmed Onsy
Chairperson
Islam Shawky
CTA in chest pain as a one stop shop
Mirvat AlAsnag
KSA
8:45 - 8:48
Discussion
8:48 - 9:03
CT in planning TAVR: NHI experience
Sarah Moharram
9:03 - 9:06
Discussion
9:06 - 9:21
NHI
CT guiding pediatric interventions
Mohamed Ghazy
9:21 - 9:24
Discussion
9:24 - 9:39
Ain Shams
CT guiding coronary interventions
Khaled El-Maghraby
9:39 - 9:42
Discussion
9:42 - 9:57
Assiut
Case Presentation
Alaa Al Anany
9:57 - 10:00
Discussion
Ain Shams
18. Tuesday, 25/Feb/2014
8:30
10:00
Hall:
Pearl II
Heart Failure and Cardiomyopathies
HF-19
HF 1
Chronic Heart Failure
Ali Ali Ramzy
Nabil Farag
Ossama Kayed
8:30 - 8:45
Ahmed Abdel Rahman
Mohamed Helmy
Chairperson
Tarek Abdel Ghaffar
Heart Failure Units; how to initiate and maintain; NHI
experience
Bassem Sobhy
NHI
8:45 - 8:48
Discussion
8:48 - 9:03
Management Algorithm for HF patients
Hussein Rizk
9:03 - 9:06
Discussion
9:06 - 9:21
Cairo
The Guidelines
Omar Awaad
Ain Shams
9:21 - 9:24
Discussion
9:24 - 9:39
Patients with limited options for coronary
revascularization
Magdy Abdel Hamid
Cairo
9:39 - 9:42
Discussion
9:42 - 9:57
HOCM program experience in NHI / MYF
Sarah Moharram
9:57 - 10:00
Discussion
NHI
19. Tuesday, 25/Feb/2014
8:30
10:00
Hall:
Coral
Hypertension
HTN-20
HTN 1
Special Topics in Hypertension
Aysar Abdel Aziz
Bassem Zarif
Mahmoud El-Badry
Chairperson
Mohamed Oraby
Mohamed Zaki
8:30 - 8:45
Arterial stiffness in HF and hypertension
Abdel Moneim Ibrahim
Cairo
8:45 - 8:50
Discussion
8:50 - 9:05
The J-Curve Phenomenon in hypertension; don’t go
very low
Essam Mahfouz
Mansoura
9:05 - 9:10
Discussion
9:10 - 9:25
JNC – 8 and the latest ESC guidelines; concepts are
changing
Hossam Kandil
9:25 - 9:30
Discussion
9:30 - 9:45
Cairo
Which drug to start with?
Nasser Taha
9:45 - 9:50
Discussion
Minia
20. Tuesday, 25/Feb/2014
8:30
10:00
Hall:
Granite
Structural Heart Disease
STR-21
STR 1
Chllenges & Controversies in Valvular
Gamal Fahim
Ossama Rifaie
Sameh Allam
8:30 - 8:45
Ahmed El-Ghalid
Nabil Gobran
STR 1Chairperson
Wael El-Nammas
Low gradient severe aortic stenosis, when to
intervene?
Mohamed Said Al-Khalifa
Sudan
8:45 - 8:50
Discussion
8:50 - 9:05
TAVI and porcelain aorta: Good results, also
published.
Pablo Avanzas
Spain
9:05 - 9:10
Discussion
9:10 - 9:25
Stress Testing in MR: When, How and Why?
Zeinab Abdel Salam
Ain Shams
9:25 - 9:30
Discussion
9:30 - 9:45
How to Use Quantitative 3-Dimensional Echo to
Guide and Assess Mitral Valve Repair
Fayez El-Shaer
9:45 - 9:50
Discussion
KSA
21. Tuesday, 25/Feb/2014
8:30
10:00
Hall:
Amber
Pediatric Cases
Ped Cas-22
Ped 4
Case Presentations
Alaa Roshdy
Hebatallah Attia
Makram Ebeid
8:30 - 8:40
Ahmed Meawad
Ghada El-Shahed
Chairperson
Sameh Arab
Case 1
Mona Hafez
8:40 - 8:45
Discussion
8:45 - 8:55
Mansoura
Case 2
Gasser Abdel Mohsen
8:55 - 9:00
Discussion
9:00 - 9:10
Cairo
Case 3
Alaa Roshdy
9:10 - 9:15
Discussion
9:15 - 9:25
Ain Shams
Case 4
Gihan El-Sawah
9:25 - 9:30
Discussion
9:30 - 9:40
Case 5
9:40 - 9:45
Discussion
9:45 - 9:55
Case 6
9:55 - 10:00
Discussion
Mansoura
23. Tuesday, 25/Feb/2014
10:00
11:30
Hall:
Blue Cany
Interventions
IHD-24
IHD 6 - CTO PCI
Case Based Session
Gamal Aboul Nasr
Mohamed El-Setiha
Mohamed Mandour
10:00 - 10:15
Amr Hassan
Hazem Khamis
Chairperson
Nabil Farag
Introduction to CTO interventions - Patient selection
– who is the right candidate.
Khaled Shoukry
10:15 - 10:18
Discussion
10:18 - 10:33
MOH
Hardware
Khalid Tamam
10:33 - 10:36
Discussion
10:36 - 10:51
NHI
Antegrade Approach
Amr Zaki
10:51 - 10:54
Discussion
10:54 - 11:09
Alexandria
Retrograde Approach
Amir Kaaki
11:09 - 11:12
Discussion
11:12 - 11:27
USA
Challenging CTO case
Imad Sheiban
11:27 - 11:30
Discussion
Italy
24. Tuesday, 25/Feb/2014
10:00
11:30
Hall:
Rock Cany
Interventions
IHD-25
IHD 7
COMBAT MI
Adel Zaki
Ahmed Nassar
Ali Ramzy
10:00 - 10:15
Adel Imam
Ahmed Kamal Metawea
Chairperson
Khaled El-Nady
New guidelines and definitions of STEMI
Francois Mach
Switzerland
10:15 - 10:18
Discussion
10:18 - 10:33
State-of-the-Art: New Devices and Techniques in
Primary PCI
Holger Thiele
10:33 - 10:36
Discussion
10:36 - 10:51
Germany
Tips and tricks in 1ry PCI
Holger Thiele
Germany
10:51 - 10:54
Discussion
10:54 - 11:09
ACS intervention in shocked patients
Neeraj Jolly
USA
11:09 - 11:12
Discussion
11:12 - 11:27
High risk patients management in Switzerland
Francois Mach
11:27 - 11:30
Discussion
Switzerland
25. Tuesday, 25/Feb/2014
10:00
11:30
Hall:
Pearl I
Echo
Echo-26
Echo 4
Advances in Echocardiography
Aziz Madkour
Hala Mahfouz
Ikram Massoud
Mohamed El-Noamany
Mona Aboul Seoud
Chairperson
Sameh Bakhoum
Zeinab Ashour
10:00 - 10:15
Tissue harmonic imaging in clinical practice
Hossam El-Gendy
UK
10:15 - 10:20
Discussion
10:20 - 10:35
The role of imaging in acute chest pain
Fausto Pinto
Portugal
10:35 - 10:40
Discussion
10:40 - 10:55
Subclinical detection of valvular heart disease using
stress echo
Sameh Samir
10:55 - 11:00
Discussion
11:00 - 11:10
Ain Shams
Challenging Case Presentation
Mohamed Ayman
11:10 - 11:15
Discussion
Alexandria
26. Tuesday, 25/Feb/2014
10:00
11:30
Hall:
Pearl II
Atherosclerosis & Dyslipidemia
ATH-27
ATH 1
Atherosclerosis & CV Risk
Emil Sadek
Fayez El-Shaer
Hussein Rizk
10:00 - 10:15
Ahmed Abdel Moneim
Ezz El-Din El-Sawy
Chairperson
Mohsen Fahmy
Between risk charts and imaging: how should we
stratify cardiovascular risk in clinical practice?
Mona Rayan
Ain Shams
10:15 - 10:18
Discussion
10:18 - 10:33
Familial hypercholesterolaemia in general population,
is underdiagnosed and undertreated
Ramzy El-Mawardy
10:33 - 10:36
Discussion
10:36 - 10:51
Ain Shams
Can we really prevent CAD.
Mahfouz El-Shahawy
USA
10:51 - 10:54
Discussion
10:54 - 11:09
Obesity and Overweight impact on CV disease
Ahmed A.Latif
Al Azhar
11:09 - 11:12
Discussion
11:12 - 11:27
The Role of Neopterin in Atherogenesis and
Cardiovascular Risk Assessment.
Pablo Avanzas
11:27 - 11:30
Discussion
Spain
27. Tuesday, 25/Feb/2014
10:00
11:30
Hall:
Coral
General Cardiology
Gen-28
Gen 1
Women @ Heart
Hanna Mikhail
Laila Shalaby
Ossama Hassan
10:00 - 10:15
Essam Mahfouz
Hossam El-Hossary
Chairperson
Sameh Allam
Relative and absolute contraindication to pregnancy
in the cardiac patient?
Khaled Tohamy
10:15 - 10:20
Discussion
10:20 - 10:35
NHI
The Challenge of Anticoagulation
Mohamed Gamal
10:35 - 10:40
Discussion
10:40 - 10:55
Military
Choice of antihypertensives
Nasser Taha
Minia
10:55 - 11:00
Discussion
11:00 - 11:15
Gender perspectives in ACS; are there any
differences?
Eva Swahn
11:15 - 11:20
Discussion
Sweden
28. Tuesday, 25/Feb/2014
10:00
11:30
Hall:
Granite
Structural Heart Disease
STR-29
STR 2
Controversies in Mitral Valve Management
Bassem Ramadan
Hossam Fawzy
Mohamed Aziz Ezzat
Mohamed Eid Fawzy
Mohamed Said Al-Khalifa
Chairperson
Ossama Rifaie
Said Rifaat
10:00 - 10:15
Imaging of the MV guiding decision making
Mohamed Ayman
Alexandria
10:15 - 10:20
Discussion
10:20 - 10:35
Asymptomatic severe MR are not always the same
Ahmed El-Hawary
Suez Canal
10:35 - 10:40
Discussion
10:40 - 10:55
When Mitral Valve Repair Is Impossible
Ossama Sayed
NHI
10:55 - 11:00
Discussion
11:00 - 11:15
Less invasive Cardiac Surgery; Future Directions and
possibilities
Hussein El-Shafei
11:15 - 11:20
Discussion
UK
29. Tuesday, 25/Feb/2014
10:00
11:30
Hall:
Amber
Heart Rhythm
ECRA-30
Mini ECRA 4
Hot Topics in Dysrrhyhtmias
Amr Kamal
Azza Katta
Haitham Badran
Hatem Kholeif
Hayam El-Damanhoury
Chairperson
Ossama Diab
10:00 - 10:12
PVC ablation and PVC related Cardiomyopathy
10:12 - 10:15
Discussion
10:15 - 10:27
Recurrent ICD discharges
Mazen Tawfik
Ain Shams
10:27 - 10:30
Discussion
10:30 - 10:42
Sudden arrhythmic cardiac death early post MI:
Mohamed Hammouda
10:42 - 10:45
Discussion
10:45 - 10:57
Cairo
Arrhythmias in heart failure
Amir Abdel Wahab
Cairo
10:57 - 11:00
Discussion
11:00 - 11:12
The patient with asymptomatic WPW, work up.
Ahmed Osman
11:12 - 11:15
Discussion
USA
30. Tuesday, 25/Feb/2014
12:00
13:00
Hall:
Blue Cany
Company Symposium
Comp Symp-32
AstraZeneca Symposium
AstraZeneca Symposium
12:00 - 12:45
New Highlights on CV Risk Management in the
Middle East
Victor F. Huckell
12:45 - 13:00
Discussion
Columbia
31. Tuesday, 25/Feb/2014
13:00
14:30
Hall:
Blue Cany
Interventions
IHD-33
IHD 8
My Stent was the best in this situation “Case Based”: including factoids
Ahmed Khashaba
Amr Zaki
Diaa El-Minshawy
13:00 - 13:09
Adel Imam
Amr Hassan
Chairperson
Magdy Abdel Hamid
Resolute Integrity
Ahmed Abdel Aziz
13:09 - 13:11
Discussion
13:11 - 13:20
Cairo
Absorb Case Presentation
Nabil Farag
13:20 - 13:22
Discussion
13:22 - 13:31
Biomatrix
13:31 - 13:33
Discussion
13:33 - 13:42
Nobori
13:42 - 13:44
Discussion
13:44 - 13:53
Ain Shams
synergy on the bright image
Hazem Khamis
13:53 - 13:55
Discussion
13:55 - 14:04
Amazonia
14:04 - 14:13
Discussion
14:13 - 14:15
6-Oct
Orsiro “Biotronik”
Stefan Hoffman
14:15 - 14:17
Discussion
Germany
32. Tuesday, 25/Feb/2014
13:00
14:00
Hall:
Rock Cany
Company Symposium
Comp Symp-34
Boehringer Ingelheim Symposium
Chairperson
Hossam Kandil
Mohamed Awad Taher
Ramzy El-Mawardy
13:00 - 13:20
When selecting an ARB…look deeper
Omar Awaad
Ain Shams
13:20 - 13:30
Discussion
13:30 - 14:00
Stroke Prevention in AF: Novel anti-coagulants
Mohamed Awad Taher
33. Tuesday, 25/Feb/2014
13:00
14:30
Hall:
Pearl II
General Cardiology
Gen-38
Gen 2
Cardiology & the Society
13:12 - 13:15
13:15 - 13:27
13:27 - 13:30
13:30 - 13:42
13:42 - 13:45
13:45 - 13:57
13:57 - 14:00
14:00 - 14:12
14:12 - 14:15
14:15 - 14:27
14:27 - 14:30
Ayman Saleh
Khairy Abdel Dayem
Matta Nashed
13:00 - 13:12
Adel Mazen
Hamdy El Sayed
Chairperson
Mohamed Helmy
Public Awareness
Laila Shalaby
NHI
Discussion
Generics in Cardiology
Sameh Allam
Al Azhar
Discussion
Exercise
Mervat Aboul Maaty
Ain Shams
Discussion
The Cardiologists role in smoking cessation in
hospital, clinic & community.
Georges Saade
Lebanon
Discussion
Smoke free hospitals
Alice Grainger Gasser
Lebanon
Discussion
Latest data on Smoking cessation, the ongoing fight
Hany Ragy
NHI
Discussion
34. Tuesday, 25/Feb/2014
13:00
14:30
Hall:
Coral
General Cardiology
Gen-39
Gen 3
Sleep & the Heart
Ahmed El-Hawary
Sameh Samir
Tarek Khairy
13:00 - 13:15
Ahmed El-Ghalid
Nabil Gobran
Chairperson
Yasser Sharaf
Sleep Apnea; prevalence and impact on the heart
Shahira Loza
Cairo
13:15 - 13:20
Discussion
13:20 - 13:35
Sleep Apnea; the cardiologist’s perspective
Bassem Zarif
NHI
13:35 - 13:40
Discussion
13:40 - 13:55
Treatment Landscape of Sleep Apnea
Ramez Reda Moustafa
13:55 - 14:00
Discussion
Egypt
35. Tuesday, 25/Feb/2014
13:00
14:30
Hall:
Granite
General Cardiology
Gen-40
Gen 4
Infective Endocarditis
Hussein Rizk
Mohamed Gamal
Mohamed Selim
13:00 - 13:15
Ahmed Kamal Metawea
Marwa Mesheal
Chairperson
Said Shalaby
Beyond Echo, non cardiac imaging in endocarditis
Marwa Mesheal
13:15 - 13:20
Discussion
13:20 - 13:35
Cairo
NHI registry
Mohamed Atef
Ain Shams
13:35 - 13:40
Discussion
13:40 - 13:55
Prophylaxis for IEC; changes in the guidelines
Karim Said
Cairo
13:55 - 14:00
Discussion
14:00 - 14:15
Antimicrobials in IEC; 10 points to remember
Iman Gadoua
14:15 - 14:20
Discussion
NHI
37. Tuesday, 25/Feb/2014
13:30
14:30
Hall:
Pearl I
Echo
Echo-37
Echo 5
Challenges in Imaging Aortic Valve Disease
Gamela Nasr
Mohamed Ayman
Sameh Zaghloul
13:30 - 13:45
Amal Ayoub
Ghada Kazamel
Chairperson
Taghreed Abdel Azim
Low gradient normal EF aortic stenosis: diagnosis
and implications for management
Sameh Bakhoum
Cairo
13:45 - 13:50
Discussion
13:50 - 14:05
Paravalvular AR post TAVR: how to quantify and
prognostic implications
Hossam El-Gendy
UK
14:05 - 14:10
Discussion
14:10 - 14:25
Dilated aortic root is not always benign
Gamela Nasr
14:25 - 14:30
Discussion
Suez Canal
38. Tuesday, 25/Feb/2014
14:00
14:30
Hall:
Rock Cany
Company Symposium
Comp Symp-35
Pfizer Symposium
Chairperson
14:00 - 14:25
Adel El-Etriby
New Guidelines and Evidence based medicine
Hany Ragy
14:25 - 14:30
Soliman Gharib
Discussion
NHI
39. Tuesday, 25/Feb/2014
14:30
15:30
Hall:
Blue Cany
Interventions
IHD-43
IHD 9
Imaging Maximizing PCI Outcomes: Lesion Assessment - FFR, IVUS
El-Sayed Farag
Mohamed Awad Taher
Nasser Taha
14:30 - 14:45
Amr Zaki
Galal El-Said
Chairperson
Sameh Salama
What is the Evidence That IVUS Can Help Me
Perform PCI Better?
Juan Rigla
Spain
14:45 - 14:50
Discussion
14:50 - 15:05
IVUS and FFR..how to utilize intracoronary physiology
and imaging in the era of OCT?
Hadi Abo Hantash
Jordan
15:05 - 15:10
Discussion
15:10 - 15:25
Why All the Fuss with FFR? If I Have A Stress Test
and Angiography
Gamal Fahim
15:25 - 15:30
Discussion
Mansoura
40. Tuesday, 25/Feb/2014
14:30
15:30
Hall:
Rock Cany
Company Symposium
Comp Symp-44
Abbott Vascular Symposium
14:30 - 14:40
Ahmed Magdy
Hany Ragy
Mohamed Sobhy
Chairperson
Sherif El-Beltagui
Absorb: Is it different?
Ehab El-Nady
14:40 - 14:45
Discussion
14:45 - 14:55
Absorb in real practice
Hazem Khamis
14:55 - 15:00
Discussion
15:00 - 15:10
6-Oct
Case presentation
Khaled Shoukry
15:10 - 15:15
Discussion
15:15 - 15:25
Military
Case presentation
Ahmed Abdel Aziz
15:25 - 15:30
Discussion
Cairo
41. Tuesday, 25/Feb/2014
14:30
15:30
Hall:
Pearl I
Echo
Echo-45
Echo 6
Echocardiography Guiding Cardiac Interventions
Hanan Kamal
Mohamed El-Noamany
Mohamed Ossama
Chairperson
Wael Abdel Aal
Walaa Adel
14:30 - 14:45
TAVI
Sameh Zaghloul
14:45 - 14:50
Discussion
14:50 - 15:05
Cairo
ASD Closure
Hebatallah Attia
15:05 - 15:10
Discussion
15:10 - 15:25
Ain Shams
TEE in mitral repair
Ahmed EL-Guindy
15:25 - 15:30
Discussion
Cairo
42. Tuesday, 25/Feb/2014
14:30
15:30
Hall:
Pearl II
Interventions
IHD-46
Hot Topics in Intervention
Hisham Hegazy
Mohamed Wafaie
Sameh Emil
14:30 - 14:42
Ashraf Reda
Hossam Kandil
Chairperson
Tarek Zaki
Management of ISR post DES; an update
Amr Hassan
Cairo
14:42 - 14:45
Discussion
14:45 - 14:57
PCI in complex cases; what are the limits?
Imad Sheiban
Italy
14:57 - 15:00
Discussion
15:00 - 15:12
PCI in patients with challenging anatomy
Sherif El-Beltagui
Alexandria
15:12 - 15:15
Discussion
15:15 - 15:27
MI in women; clinical and technical points
Moustafa El-Sayed
15:27 - 15:30
Discussion
Al Azhar
43. Tuesday, 25/Feb/2014
14:30
15:30
Hall:
Coral
General Cardiology
Gen-47
Gen 5
Myopericardial Disease
Fahim Ragab
Ihab El-Kholy
Mohamed Gamal Abdel Bar
14:30 - 14:45
Assem Fathy
Hisham Khorshid
Chairperson
Nabil Malaty
Acute pericarditis approach and management
Adel Mazen
14:45 - 14:50
Discussion
14:50 - 15:05
Al Azhar
ECG may be misleading
Samir Rafla
Alexandria
15:05 - 15:10
Discussion
15:10 - 15:25
Approach for acute myocarditis
Ali Kassem
Ali Kassem
Sohag
15:25 - 15:30
Discussion
15 min
44. Tuesday, 25/Feb/2014
14:30
15:30
Hall:
Granite
General Cardiology
Gen-48
Gen 6
Clinical Pharmacy "1"
Ayman El Naggar
Omar Awaad
Samar Farid
14:30 - 14:45
Ahmed Abdel Moneim
Hossam El-Shaer
Chairperson
Soliman Gharib
Anticoagulants the new era
Emam Mahmoud
NHI
14:45 - 14:50
Discussion
14:50 - 15:05
New equation for accurate dosing of warfarin
Naglaa Bazaan
Cairo
15:05 - 15:10
Discussion
15:10 - 15:25
An overview of antiarrhythmic drugs
Karim Ibrahim
15:25 - 15:30
Discussion
Salam In.Hosp
48. Tuesday, 25/Feb/2014
15:30
17:00
Hall:
Pearl II
Heart Failure and Cardiomyopathies
HF-54
HF 2
CChallenges in Heart Transplant
Mahmoud Hassanein
Mohamed El-Senbesy Joint
Mohamed Wafaie
Chairperson
Said Khaled
Wafaa El-Aroussy
15:30 - 15:44
Management of refractory heart failure
Magdy Abdel Hamid
Cairo
15:44 - 15:48
Discussion
15:48 - 16:02
Management of Advanced Heart Failure, Options in
the Middle East
Walid Al Habeeb
KSA
16:02 - 16:06
Discussion
16:06 - 16:20
Heart transplantation updates in surgical perspectives
Hani Najm
16:20 - 16:24
Discussion
16:24 - 16:38
KSA
VADs current status
Walid Al Habeeb
KSA
16:38 - 16:42
Discussion
16:42 - 16:56
Heart Failure and cardiac transplant in Saudi Arabia
Abdel Fattah El-Asfar
16:56 - 17:00
Discussion
KSA
49. Tuesday, 25/Feb/2014
15:30
17:00
Hall:
Coral
General Cardiology
Gen-55
Gen 7
Important Usually Forgotten Topics
Farouk Radwan
Hussein Rizk
Mohamed Gamal
15:30 - 15:45
Ali Kassem
Fouad El-Nawawy
Chairperson
Nasser Taha
Thyroid disease and the Heart; are we missing the
diagnosis?
Hisham Nasr
NHI
15:45 - 15:48
Discussion
15:48 - 16:03
Cardiac Complications of Chemotherapy
Tamer El-Nahhas
Cairo
16:03 - 16:06
Discussion
16:06 - 16:21
Erectile dysfunction in the cardiac patient
Tarek Abdel Rahman
Minia
16:21 - 16:24
Discussion
16:24 - 16:39
Vasculitis and Collagen disease in the cardiac patient
Magdy El-Gohary
Assiut
16:39 - 16:42
Discussion
16:42 - 16:57
Gene and stem cell therapy; ready or not yet?
Sanaa Abdel Shafy
16:57 - 17:00
Discussion
Cairo
50. Tuesday, 25/Feb/2014
15:30
17:00
Hall:
Granite
Structural Heart Disease
STR-56
STR 3
Hot Topics in Valvular Heart Disease
Khairy Abdel Dayem
Mortaga Negm
Moustafa Agha
15:30 - 15:45
Fathy Maklady
Mohamed El-Maraghy
Chairperson
Sameh El-Amin
State of the Art: Mitral Valvuloplasty
Mohamed Eid Fawzy
6-Oct
15:45 - 15:48
Discussion
15:48 - 16:03
Management of critical aortic stenosis from inotropes
to valvuloplasty
16:03 - 16:06
Discussion
16:06 - 16:21
MV scores; how they guide my approach?
Ossama Rifaie
16:21 - 16:24
Discussion
16:24 - 16:39
Surgical Challenges in patients with IEC
Mohamed Nasr
16:39 - 16:42
Discussion
16:42 - 16:57
NHI
Tricuspid valve; the forgotten
Gamal Sami
16:57 - 17:00
Discussion
Ain Shams
51. Tuesday, 25/Feb/2014
15:30
17:00
Hall:
Amber
Acute Cardiac Care
ACC-125
ACCC 6
Pulmonary Embolism
Hazem Khorshid
Mohamed Abdel Shafy Tabl
Salah El-Tahan
15:30 - 15:45
Hassan Shehata
Magdy Badie
Chairperson
Tarek Aziz
DVT in 2014; what do you need to know?
Khaled Leon
NHI
15:45 - 15:48
Discussion
15:48 - 16:03
Risk stratification and Clinical Management
Hisham Selim
16:03 - 16:06
Discussion
16:06 - 16:21
Role of Imaging in the diagnosis of PE
Islam Shawky
Al Azhar
16:21 - 16:24
Discussion
16:24 - 16:39
Pharmacologic Treatment of Pulmonary Embolism
Mohamed Selim
16:39 - 16:42
Discussion
16:42 - 16:57
Invasive Management
Maher Edler
16:57 - 17:00
Discussion
USA
53. Tuesday, 25/Feb/2014
15:30
16:30
Hall:
Lunch & Learn
Lun&Lear-58
Lunch & Learn
Sponsored By ( Sanofi
Chairperson
15:30 - 16:30
)
Mohamed Zaki
Role of ARBs in the New Hypertension Guidelines
(ESH 2013 & JNC 8)
Mohamed Selim
NHI
Turquoise
54. Wednesday, 26/Feb/2014
8:30
10:00
Hall:
Blue Cany
Interventions
IHD-59
IHD 11
COMBAT MI Session: Heart Attack Programs
8:42 - 8:45
8:45 - 8:57
8:57 - 9:00
9:00 - 9:12
9:12 - 9:15
9:15 - 9:27
9:27 - 9:30
9:30 - 9:42
9:42 - 9:45
9:45 - 9:57
9:57 - 10:00
Hisham Salah
Mohamed Al Jarallah
Omar Awaad
8:30 - 8:42
Adel El-Etriby
Maged El-Abbady
Chairperson
Sherif El-Tobgy
Heart Attack Programs in Egypt
Ahmed Mohannad
NHI
Discussion
Heart Attack programs in Europe
Hany Eteiba
UK
Discussion
Heart Attack programs in USA
Maher Edler
USA
Discussion
Heart Attack programs in India
Alexander Thomas
India
Discussion
Challenges of primary PCI in the gulf
Abdallah Shehab
UAE
Discussion
Primary PCI experience in a tertiary center in Kuwait
“Al-Sabbah”
Gamal Aboul Nasr
NHI
Discussion
55. Wednesday, 26/Feb/2014
8:30
10:00
Hall:
Rock Cany
Interventions
IHD-60
IHD 12
Searching for the Culprit Lesion
Abdallah El-Agha
Ahmed El-Sayed
Hany Ragy
Chairperson
Mona Rayan
Sameh Salama
8:30 - 8:45
Role of nuclear medicine in 2014
Adel Allam
8:45 - 8:48
Discussion
8:48 - 9:03
Al Azhar
CT – FFR
Mirvat AlAsnag
9:03 - 9:06
Discussion
9:06 - 9:21
KSA
Role of CMR
Fabiola Sozzi
Italy
9:21 - 9:24
Discussion
9:24 - 9:39
Imaging of the Vulnerable plaque in 2014
Stefan Hoffman
9:39 - 9:42
Discussion
9:42 - 9:57
Germany
IVUS for complex lesions
Juan Rigla
9:57 - 10:00
Discussion
Spain
56. Wednesday, 26/Feb/2014
8:30
10:00
Hall:
Pearl I
TAVI
TAVI-61
STR 6
TAVI in 2014
8:30 - 8:42
Ahmed Khattab
Ahmed Magdy
Nabil Farag
Chairperson
Taher El-Kady
Asymptomatic severe aortic valve disease
Ahmed Shafie Ammar
8:42 - 8:45
Discussion
8:45 - 8:57
Zagazig
State of the Art: Recent trials
Hamdy Soliman
NHI
8:57 - 9:00
Discussion
9:00 - 9:12
Challenges before; during and after TAVI
Ahmed Khashaba
Ain Shams
9:12 - 9:15
Discussion
9:15 - 9:27
Risk stratification and imaging are crucial to success
Mauro Cassese
9:27 - 9:30
Discussion
9:30 - 10:00
Italy
Live in a box
Ahmed Khattab
Switzerland
57. Wednesday, 26/Feb/2014
8:30
10:00
Hall:
Pearl II
Heart Failure and Cardiomyopathies
HF-62
HF 3
Hot topics in Heart Failure
Adel Abdel Aziz
Bassem Sobhy
Hatem El-Atroush
HFChairperson
Khaled El-Khashab
Ossama Sanad
8:30 - 8:44
Chronic HF; are we missing the underlying cause?
Hossam El-Araby
8:44 - 8:48
Discussion
8:48 - 9:02
Assiut
Cardiovascular imaging in HF
Fausto Pinto
Portugal
9:02 - 9:06
Discussion
9:06 - 9:20
The influence of DM on the management of HF
Tarek El-Zawawy
Alexandria
9:20 - 9:24
Discussion
9:24 - 9:38
Choosing the glucose lowering drug in patients with
DM and HF
Inas Shaltout
Cairo
9:38 - 9:42
Discussion
9:42 - 9:56
Coronary revascularization in patients with LV
aneurysm
Sherif Hindawy
9:46 - 10:00
Discussion
NHI
58. Wednesday, 26/Feb/2014
8:30
10:00
Hall:
Coral
Acute Cardiac Care
ACC-63
ACCC 3
Acute Heart Failure; new era or the same old problems
8:30 - 8:45
Abdel Moneim Ibrahim
Essam Mahfouz
Tarek Naguib
Chairperson
Yousry Kamel
The Vascular Mechanism
Ihab El-Hifny
8:45 - 8:50
Discussion
8:50 - 9:05
Al Azhar
Diagnosis and assessment
Ossama Amin
Banisuef
9:05 - 9:10
Discussion
9:10 - 9:25
Patient with acute heart failure and ACS, case review
Essam Baligh
Cairo
9:25 - 9:30
Discussion
9:30 - 9:45
Patient with low output failure; case review
Uwe Zymer
9:45 - 9:50
Discussion
Germany
59. Wednesday, 26/Feb/2014
8:30
10:00
Hall:
Granite
Hypertension
HTN-64
HTN 2
Hypertension in Special Situations
8:30 - 8:45
Helmy El-Ghawaby
Hossam Kandil
Saad Ammar
Chairperson
Tamer Abu Arab
White Coat and Masked Hypertension
Hany Abdel Razek
NHI
8:45 - 8:48
Discussion
8:48 - 9:03
Hypertensive Urgencies; how to treat?
Ahmed Yehia Hegab
9:03 - 9:06
Discussion
9:06 - 9:21
NHI
Drug Induced Hypertension
Sharaf El-Din El-Shazly
Sohag
9:21 - 9:24
Discussion
9:24 - 9:39
Perioperative management of hypertension
Walid Hammady
Ain Shams
9:39 - 9:42
Discussion
9:42 - 9:57
Management of hypertension during the acute phase
of stroke
Abdel Rahman Hassan
9:57 - 10:00
Discussion
NHI
60. Wednesday, 26/Feb/2014
8:30
10:00
Hall:
Amber
Imaging
IMG-65
IMG 1
Merits of Imaging
Chairperson
Mokhtar Gomaa
Abdel Rahman Sharaf
Ahmed Abdel Aaty
Aziz Madkour
Kawkab Khedr
Mohamed El-Gabaly
8:30 - 8:45
Aliaa Abdel Fattah
Salah Demerdash
Risk assessment with myocardial perfusion; is it
beneficial?
Ahmed Salah
8:45 - 8:50
Discussion
8:50 - 9:00
Case Presentation
9:00 - 9:04
Discussion
9:04 - 9:14
Case Presentation
9:14 - 9:18
Discussion
9:18 - 9:28
Case Presentation
9:28 - 9:32
Discussion
9:32 - 9:42
Case Presentation
9:42 - 9:46
Discussion
9:46 - 9:56
Case Presentation
9:56 - 10:00
Discussion
NHI
62. Wednesday, 26/Feb/2014
10:00
11:30
Hall:
Blue Cany
Interventions
IHD-67
IHD 13
LM PCI
Galal El-Said
Ibrahim Khadragui
Magdy Moustafa
10:00 - 10:15
Adel El-Etriby
Gamal Sami
Chairperson
Sherif El-Beltagui
State of the Art Lecture on Left Main PCI: An
Interventionist’s Perspective - 2014 & beyond
Hany Eteiba
UK
10:15 - 10:18
Discussion
10:18 - 10:33
Functional and Anatomic Assessment of Left Main
Amir Kaaki
USA
10:33 - 10:36
Discussion
10:36 - 10:51
Technical challenges in LM PCI: “Case Based”
Azeem Latib
Italy
10:51 - 10:54
Discussion
10:54 - 11:09
Unprotected LM PCI: safety, feasibility & beyond
Mohamed Salem
11:09 - 11:12
Discussion
11:12 - 11:27
UAE
Emergency bypass surgery
Amr El-Sakka
11:27 - 11:30
Discussion
USA
63. Wednesday, 26/Feb/2014
10:00
11:30
Hall:
Rock Cany
Interventions
IHD-68
IHD 10
COMBAT MI Session
Magdy Abdel Hamid
Moustafa El-Sayed
Ramez Guindy
10:00 - 10:15
Gamal Aboul Nasr
Mamdouh El-Tahan
Chairperson
Sameh Emil
Pre-hospital management of STEMI
Helmy El-Ghawaby
Cairo
10:15 - 10:18
Discussion
10:18 - 10:33
Role of hs troponin and the new biomarkers
Eva Swahn
Sweden
10:33 - 10:36
Discussion
10:36 - 10:51
Pharmaco-invasive approach (1ry or facilitated)
Alexander Thomas
India
10:51 - 10:54
Discussion
10:54 - 11:09
Should DES in primary PCI be the default?
Habib Gamrah
Tunisia
11:09 - 11:12
Discussion
11:12 - 11:27
Primary PCI in the presence of large thrombus
burden
Sameh Shaheen
11:27 - 11:30
Discussion
Ain Shams
64. Wednesday, 26/Feb/2014
10:00
11:30
Hall:
Pearl I
Structural Heart Disease
STR-69
STR 5
New Techniques & Devices
10:00 - 10:15
Hamdy Soliman
Magdy El-Masry
Mohamed El-Badrawy
Chairperson
Nasser Taha
Management of severe MR
Hazem Khamis
10:15 - 10:20
Discussion
10:20 - 10:35
6-Oct
The Watchmann Device
Nabil Farag
10:35 - 10:40
Discussion
10:40 - 10:55
Ain Shams
TAVI; valves in the pipeline
Ahmed Khattab
Switzerland
10:55 - 11:00
Discussion
11:00 - 11:15
TAVI and the other on mininvasive aortic substitution
with sutureless prosthesis (Intuity valve).
Mauro Cassese
11:15 - 11:20
Discussion
Italy
65. Wednesday, 26/Feb/2014
10:00
11:30
Hall:
Pearl II
Atherosclerosis & Dyslipidemia
ATH-70
ATH 2
Atherosclerosis & CV Risk
Ahmed Yehia Hegab
Ramzy El-Mawardy
Sayed Abdel Hafiz
10:00 - 10:15
Ahmed A.Latif
Mokhtar Gomaa
Chairperson
Tarek El-Zawawy
Risk profile in the Egyptians
Ashraf Reda
10:15 - 10:20
Discussion
10:20 - 10:35
Menoufia
Risk charts and risk calculators
David Wood
UK
10:35 - 10:40
Discussion
10:40 - 10:55
Incidence of DM by statins vs. statins benefits
Atef El-Bahry
Port Said
10:55 - 11:00
Discussion
11:00 - 11:15
Aggressive lipid Lowering after the new guidelines;
where did we go?
Moussa Akbar
11:15 - 11:20
Discussion
66. Wednesday, 26/Feb/2014
10:00
11:30
Hall:
Coral
Acute Cardiac Care
ACC-71
ACCC 4
Acute Aortic Syndrome
Ali Saad
Hossam El-Araby
Medhat El-Ashmawy
10:00 - 10:15
Ahmed Shafie Ammar
Hany Abdel Razek
Chairperson
Sherif Samir
Approach to the patient with severe chest pain and
normal ECG
Azza El-Eraky
10:15 - 10:20
Discussion
10:20 - 10:35
Ismailia
Imaging of the AAS
Fabiola Sozzi
10:35 - 10:40
Discussion
10:40 - 10:55
Italy
Medical Management
Ahmed Abdallah
10:55 - 11:00
Discussion
11:00 - 11:15
NHI
Surgical Management
Said Abdel Aziz
11:15 - 11:20
Discussion
Cairo
67. Wednesday, 26/Feb/2014
10:00
11:30
Hall:
Granite
General Cardiology
Gen-72
Gen 8
Miscellaneous Topics
Chairperson
Amal Rizk
Mohamed Abdel Aziz Tayel
Montaser El-Sekely
10:00 - 10:15
The rare cardiac disorders
Hany Ragy
10:15 - 10:18
Sharaf El-Din El-Shazly
NHI
Discussion
10:18 - 10:33
Bassem Sobhy
10:33 - 10:36
Discussion
10:36 - 10:51
NHI
Bridging Cardiology & Oncology
Taher El-Kady
10:51 - 10:54
Discussion
10:54 - 11:09
NHI
Genetics and Cardiology
Ramez Sam
11:09 - 11:12
Discussion
11:12 - 11:27
Herbal Therapy & Homeopathy
Ahmed Rozza
11:27 - 11:30
Discussion
Cairo
68. Wednesday, 26/Feb/2014
10:00
11:30
Hall:
Amber
Heart Rhythm
ECRA-73
Mini ECRA 5
Syncope & Channelopathies
Gamal Shaaban
Said Khaled
Samir Rafla
10:00 - 10:15
Ayman Morttada
Hisham El-Aasar
Chairperson
Sherif El-Degwy
Approach to patient with sncope
Hassan Khaled
10:15 - 10:18
Discussion
10:18 - 10:33
Cairo
QT Syndromes
Ossama Diab
10:33 - 10:36
Discussion
10:36 - 10:51
Ain Shams
Brugada syndrome case review
Khaled Shaheen
Egypt
10:51 - 10:54
Discussion
10:54 - 11:09
Raised J-point syndrome, what is behind?
Ashraf El-Shalakany
USA
11:09 - 11:12
Discussion
11:12 - 11:27
Sudden cardiac death in the very young
Marwan Refaat
11:27 - 11:30
Discussion
Lebanon
69. Wednesday, 26/Feb/2014
12:00
13:00
Hall:
Blue Cany
Company Symposium
Comp Symp-75
MSD Symposium
Mohamed Sobhy
Ramez Guindy
Salah Shelbaya
Chairperson
Sherif El-Tobgy
Tarek El-Zawawy
12:00 - 12:15
What’s new in hypertension?
Hossam Kandil
12:15 - 12:20
Discussion
12:20 - 12:35
Cairo
Bring more patients to goal
Ramzy El-Mawardy
Ain Shams
12:35 - 12:40
Discussion
12:40 - 12:55
Control diabetes with no compromise
Adel El-Etriby
12:55 - 13:00
Discussion
Ain Shams
71. Wednesday, 26/Feb/2014
14:00
15:00
Hall:
Blue Cany
Interventions
IHD-77
IHD 15
Innovations in Cardiology “2”
Ahmed Khashaba
Ihab Attia
Mohamed Badawi
Mohamed El-Setiha
Mohamed Sobhy
14:00 - 14:12
Ahmed El-Kirdany
Ahmed Saleh
Chairperson
Wael El-Naggar
Intervention can reach new areas
Amir Kaaki
14:12 - 14:15
Discussion
14:15 - 14:27
USA
Stents of tomorrow will be better
Azeem Latib
14:27 - 14:30
Discussion
14:30 - 14:42
Italy
Advances in Cardiac Surgery
Hussein El-Shafei
UK
14:42 - 14:45
Discussion
14:45 - 14:57
Newer antihypertensives; do they meet the
expectations?
Wafaa El-Aroussy
14:57 - 15:00
Discussion
Cairo
72. Wednesday, 26/Feb/2014
14:00
15:00
Hall:
Rock Cany
Interventions
IHD-78
IHD 16
COMBAT MI Session
14:00 - 14:12
Ahmed Salah
Helmy El-Ghawaby
Mohamed Gharib
Chairperson
Mohamed Wafaie
Angina with normal coronaries
Hamza Kabil
Banha
14:12 - 14:15
Discussion
14:15 - 14:27
Echocardiography in acute chest pain
Mohamed Ayman
Alexandria
14:27 - 14:30
Discussion
14:30 - 14:42
Perfusion imaging in acute chest pain
Aliaa Abdel Fattah
Cairo
14:42 - 14:45
Discussion
14:45 - 14:57
Cardiac CT angiography in acute chest pain
Ashraf Badawi
14:57 - 15:00
Discussion
Cairo
73. Wednesday, 26/Feb/2014
14:00
15:00
Hall:
Pearl I
Echo
Echo-79
Echo 8
Practical Points in Quantitative Echocardiography
Azza El-Eraky
Islam Sherbiny
Mohamed Ayman
Chairperson
Salwa Swelaim
Tarek Khalil
14:00 - 14:15
Doppler hemodynamics: which track to pick?
Amal Hamdy
14:15 - 14:20
Discussion
14:20 - 14:35
Al Azhar
3-D Quantitation: when to use?
Ahmed El-Missiri
14:35 - 14:40
Discussion
14:40 - 14:55
Ain Shams
Strain in real world practice
Hossam El-Gendy
14:55 - 15:00
Discussion
UK
74. Wednesday, 26/Feb/2014
14:00
15:00
Hall:
Pearl II
Imaging
IMG-80
IMG 3
Imaging for viability; is it still viable?
Abdel Rahman Sharaf
Adel Allam
Ebtihag Hamdy
Eman El-Sharkawy
Mohamed Mandour
Chairperson
Mona Rayan
Salah Demerdash
14:00 - 14:15
Role of stress echocardiography
Zeinab Ashour
14:15 - 14:20
Discussion
14:20 - 14:35
Cairo
SPECT / PET
Ahmed Abdel Aaty
14:35 - 14:40
Discussion
14:45 - 14:55
CMR; the radiation-less future
Abdallah El-Agha
14:55 - 15:00
Discussion
Alexandria
75. Wednesday, 26/Feb/2014
14:00
15:00
Hall:
Coral
General Cardiology
Gen-81
Gen 9
Pulmonary Hypertension
Ahmed Yehia Hegab
Kamal Saad Mansour
Khaled Baraka
14:00 - 14:15
Abo Bakr El-Seddik
Hisham Hassan
Chairperson
Medhat El-Ashmawy
Assessment and risk
Walid Abdou
Menoufia
14:15 - 14:20
Discussion
14:20 - 14:35
Medical therapy; what’s coming up?
Nashwa El-Hagrassy
6-Oct
14:35 - 14:40
Discussion
14:40 - 14:55
Severe PH; when intervention is still possible?
Hossam Bahy
14:55 - 15:00
Discussion
NHI
76. Wednesday, 26/Feb/2014
14:00
15:00
Hall:
Granite
General Cardiology
Gen-82
Gen 10
Clinical Pharmacy "2"
Ahmed Zaghloul
Magdy Abdel Samie
Nirmeen Sabry
14:00 - 14:15
Ahmed Rozza
Hany Abdel Razek
Chairperson
Tarek Zaki
Digoxin holiday; is it still needed?
Sahar Atef
Cairo
14:15 - 14:20
Discussion
14:20 - 14:35
Inotropes; it’s never the end Nehal Abdel Khalek 15 min
Nehal Abdel Khalek
NHI
14:35 - 14:40
Discussion
14:40 - 14:55
If it is refractory .. Ask the pharmacist; Case
presentation
Marwa El-Sayed
14:55 - 15:00
Discussion
Cairo
77. Wednesday, 26/Feb/2014
14:00
15:00
Hall:
Amber
Heart Rhythm
ECRA-83
Mini ECRA 6
Arrhyhtmic Emergencies in the CCU
Gamal Shaaban
Mervat Aboul Maaty
Samir Rafla
14:00 - 14:12
Eman El-Safty
Hassan Khaled
Chairperson
Wagdy Galal
VT/VF during primary PCI
Hisham El-Aasar
14:12 - 14:15
Discussion
14:15 - 14:27
Cairo
Atrial fibrillation during ACS
Haitham Badran
Ain Shams
14:27 - 14:30
Discussion
14:30 - 14:42
Arrhythmias complicating cardiac surgeries
Ahmed Ragab
NHI
14:42 - 14:45
Discussion
14:45 - 14:57
Pacemakers for the TAVI patient: For whom? When?
Mohamed Ossama
14:57 - 15:00
Discussion
NHI
79. Wednesday, 26/Feb/2014
16:00
17:30
Hall:
Blue Cany
Interventions
IHD-86
IHD 7
Barriers to Adoption of New Pharmacologies in ACS
16:12 - 16:15
16:15 - 16:27
16:27 - 16:30
16:30 - 16:42
16:42 - 16:45
16:45 - 16:57
16:57 - 17:00
17:00 - 17:12
17:12 - 17:15
17:15 - 17:27
17:27 - 17:30
Hisham Aboul Einen
Mohamed Abdel Ghani
Mohamed Sobhy
16:00 - 16:12
Hany Ragy
Mamdouh Warda
IHD 7Chairperson
Tarek Zaki
Novel Oral Antiplatelet; where do we stand?
Adel El-Etriby
Ain Shams
Discussion
Anti-Platelet Therapy in STEMI; current status
Uwe Zymer
Germany
Discussion
Our ACS Patients Are Old, Sick Small Women: The
Prasugrel Label as a Barrier to Adoption
Sameh Emil
Military
Discussion
Ticagrelor; why still not in the first line?
Ahmed Zaghloul
Tanta
Discussion
Glycoprotein Inhibition and Bivalirudin – Mixed
Clinical Trial Signals As a Barrier to Widespread
Adoption
Ramez Guindy
Ain Shams
Discussion
How to manage patients on DAPT before emergency
surgery?
Mohamed Helmy
NHI
Discussion
80. Wednesday, 26/Feb/2014
16:00
17:30
Hall:
Rock Cany
Interventions
IHD-87
IHD 18 - Complex Interventions
Hamdy El Sayed
Khaled Karara
Mohamed M. El-Fiky
16:00 - 16:15
Amin Fouad
Ihab Attia
Chairperson
Sherif El-Beltagui
Debate: Complex PCI vs CABG .. the endless debate
.. theory to discuss and real life cases to share..
Mohamed Emara
16:15 - 16:30
NHI
Debate: Complex PCI vs CABG .. The endless debate
.. Theory to discuss and real life cases to share..
Hadi Abo Hantash
16:30 - 16:45
Jordan
Bifurcation techniques; which technique for which
lesion?
Ahmed Magdy
NHI
16:45 - 16:50
Discussion
16:50 - 17:05
Do we need unusual approaches in bifurcation PCI?
Ahmed Fathy
17:05 - 17:10
Discussion
NHI
81. Wednesday, 26/Feb/2014
16:00
17:30
Hall:
Imaging
IMG-88
IMG 4
Cardiac Imaging Guiding Therapy
Ashraf Galal
Islam Shawky
Mahmoud Hassan Shah
16:00 - 16:15
Ahmed Abdel Aaty
Hanaa Fereig
Chairperson
Zeinab Ashour
Dyssynchrony or discoordination imaging before
CRT; are we any wiser now?
Wafaa El-Aroussy
Cairo
16:15 - 16:20
Discussion
16:20 - 16:35
Imaging guiding LAA occlusion and mitraclip
Ahmed El-Sayed
Ain Shams
16:35 - 16:40
Discussion
16:40 - 16:55
Perfusion guided coronary revascularization; is it still
relevant in the era of CTA?
Ahmed Magdy Moustafa
Military
16:55 - 17:00
Discussion
17:00 - 17:15
Echo or CT or both in sizing the aortic annulus
before TAVR?
Fabiola Sozzi
17:15 - 17:20
Discussion
Italy
Pearl I
82. Wednesday, 26/Feb/2014
16:00
17:30
Hall:
Heart Failure and Cardiomyopathies
HF-89
HF 4
Acute Heart Failure
Bassem Sobhy
Hamza Kabil
Hossam Bahy
Magdy El-Masry
Mohamed Salem El-Baz
Chairperson
Wagdy Ayad
16:00 - 16:15
Relaxin; does it meet the emerging data?
16:15 - 16:20
Discussion
16:20 - 16:35
Newer inotropes
Magdy El-Masry
16:35 - 16:40
Discussion
16:40 - 16:55
Tanta
Novel natriuretic peptides
Wael El-Kilany
16:55 - 17:00
Discussion
17:00 - 17:15
Ain Shams
Role of ultrafiltration
Adel El-Ansary
17:15 - 17:20
Discussion
Ain Shams
Pearl II
83. Wednesday, 26/Feb/2014
16:00
17:30
Hall:
Coral
Acute Cardiac Care
ACC-90
ACCC 5
Non Coronary Emergencies
Ikram Sadek
Mohamed Farid El-Gendy
Mohamed Selim
16:00 - 16:15
Adel El-Banna
Mesbah Taha Hassanein
Chairperson
Ragab Abdel Salam
Devices used in Cardiogenic shock
Uwe Zymer
16:15 - 16:18
Discussion
16:18 - 16:33
Germany
Prosthetic Valve Emergencies
Ghada Kazamel
NHI
16:33 - 16:36
Discussion
16:36 - 16:51
Stress induced cardiomyopathy (Takotsubo)
Eman El-Sharkawy
Alexandria
16:51 - 16:54
Discussion
16:54 - 17:09
The unstable patient with severe aortic stenosis
Mohamed El-Maraghy
NHI
17:09 - 17:12
Discussion
17:12 - 17:27
Early complications after cardiac surgery – the
cardiologist’s perspective
Ahmed Abdel Aziz
17:27 - 17:30
Discussion
Cairo
84. Wednesday, 26/Feb/2014
16:00
17:30
Hall:
Granite
Atherosclerosis & Dyslipidemia
ATH-91
ATH 3
Atherosclerosis & CV risk
Atef El-Bahry
Mohamed Farid El-Gendy
Mohsen Salama
16:00 - 16:15
Ahmed El-Boghdady
Fayez Fayek
Chairperson
Ramzy El-Mawardy
New therapeutic principles: focus on HDL raising and
Lp(a) lowering drugs.
Tarek Abdel Ghaffar
NHI
16:15 - 16:20
Discussion
16:20 - 16:35
Critical Review of Non-Statin treatments for
dyslipidemias
David Wood
UK
16:35 - 16:40
Discussion
16:40 - 16:55
The new guidelines; concepts are changing.
Mohamed Wafaie
16:55 - 17:00
Discussion
17:00 - 17:15
Zagazig
Drugs in the Pipeline
Mahfouz El-Shahawy
17:15 - 17:20
Discussion
USA
85. Wednesday, 26/Feb/2014
16:00
17:30
Hall:
Amber
Pediatric Cardiology
Ped-92
Ped 7
Interventions in the Critically ill Infants
Alyaa Kotby
Mohamed Hamed
Sonia El-Seady
16:00 - 16:15
Alaa Roshdy
Khaled Sorour
Chairperson
Zeinab Salah
Interventions in hypoplastic aortic arch
Shakeel Qureshi
UK
16:15 - 16:18
Discussion
16:18 - 16:33
Catheter and surgical collaboration / hybrid
procedures in the management of the critically ill
infant
Makram Ebeid
16:33 - 16:36
Discussion
16:36 - 16:51
USA
Neonatal bedside intervention
Amal El-Sisi
Cairo
16:51 - 16:54
Discussion
16:54 - 17:09
Femoral arterial access in pediatrics and a proposed
protocol and use of TPA
Howaida El-Said
USA
17:09 - 17:12
Discussion
17:12 - 17:27
Transcatheter interventions in the newborn
Hala El-Marsafawy
17:27 - 17:30
Discussion
Mansoura
87. Thursday, 27/Feb/2014
8:30
10:00
Hall:
Blue Cany
Interventions
IHD-94
IHD 19
Multivessel Interventions
Adel El-Etriby
Ali Ramzy
Amin Fouad
Anwar Balbaa
Ezz El-Din Moustafa
Chairperson
Mohamed Emara
Mohamed Mandour
8:30 - 8:42
8:42 - 8:45
8:45 - 8:57
8:57 - 9:00
9:00 - 9:12
9:12 - 9:15
9:15 - 9:27
9:27 - 9:30
9:30 - 9:42
9:42 - 9:45
9:45 - 9:57
9:57 - 10:00
Multivessel PCI in Non-Diabetics: Clinical and
Technical Considerations
Magdy El-Khadem
Discussion
PCI in multivessel diabetics; when and why?
Taher El-Kady
NHI
Discussion
Approach for Multivessel Disease in STEMI
Mohamed Sobhy
Alexandria
Discussion
New scores for stratifying the risk in stenting
coronary artery disease
Antoine Lafont
France
Discussion
CABG redo; where are we?
Adel El-Banna
NHI
Discussion
Hybrid revascularization: is it prime time?
Mohamed Salem
UAE
Discussion
88. Thursday, 27/Feb/2014
8:30
10:00
Hall:
Rock Cany
Interventions
IHD-95
IHD 20
Hot Topics in Cardiac Pharmacology
Ali Ahmed
Mahmoud Hassanein
Nerin Okasha
8:30 - 8:45
Alaa Hataba
Maged El-Abbady
Chairperson
Ossama Sanad
Clopidogrel allergy and resistance
Montaser El-Sekely
8:45 - 8:48
Discussion
8:48 - 9:03
Zagazig
New stents and duration of DAPT
Hazem Warda
9:03 - 9:06
Discussion
9:06 - 9:21
Alexandria
Patients on OAC in need for PCI
Medhat El-Ashmawy
Tanta
9:21 - 9:24
Discussion
9:24 - 9:39
Dyslipidemia with CLD; how to manage?
Ahmed Boghdady
Sohag
9:39 - 9:42
Discussion
9:42 - 9:57
LMWH for elective PCI; what went wrong?
Yasser Boghdady
9:57 - 10:00
Discussion
Cairo
89. Thursday, 27/Feb/2014
8:30
10:00
Hall:
Pearl I
Echo
Echo-96
Echo 9
Echocardiography Challenges
Azza El-Eraky
Fawzeya Demerdash
Mohamed Ayman
8:30 - 8:45
Ahmed El-Missiri
Eman El-Sharkawy
Chairperson
Wafaa El-Aroussy
Patients with chest pain and normal ECG
Tarek El-Kholy
8:45 - 8:48
Discussion
8:48 - 9:03
Cairo
Hypotensive shock
Mohamed Ossama
9:03 - 9:06
Discussion
9:06 - 9:21
NHI
RV; the forgotten piece
Mona Aboul Seoud
9:21 - 9:24
Discussion
9:24 - 9:39
Cairo
Contrast echo; role in 2014
Hala Mahfouz
9:39 - 9:42
Discussion
9:42 - 9:57
Menoufia
Acute Mitral Regurgitation
Sanaa Ashour
9:57 - 10:00
Discussion
Alexandria
90. Thursday, 27/Feb/2014
8:30
10:00
Hall:
Pearl II
General Cardiology
Gen-97
Gen 11
Heart & Kidney
Diaa Dardeer
Ossama Abdel Moemen
Tarek El-Zawawy
8:30 - 8:45
Ashraf Reda
Hamza Kabil
Chairperson
Yehia Kishk
Choice of antihypertensives
Salwa Roshdy
8:45 - 8:48
Discussion
8:48 - 9:03
Military
PCI in the renal patient
Hisham Aboul Einen
Banha
9:03 - 9:06
Discussion
9:06 - 9:21
Renal protection for the cardiac patient; what do we
need to know?
Omar El-Khashab
Cairo
9:21 - 9:24
Discussion
9:24 - 9:39
The Cardiac Patient after Renal Transplantation
Hany Fouad
Cairo
9:39 - 9:42
Discussion
9:42 - 9:57
Renal Artery Stenting; current status
Reda El-Eisawy
9:57 - 10:00
Discussion
Military
91. Thursday, 27/Feb/2014
8:30
10:00
Hall:
Coral
Acute Cardiac Care
ACC-98
ACCC 6
Diabetes in Acute Cardiac Events
Fathia El-Sheshtawy
Hany Ragy
Heba Mansour
8:30 - 8:45
Charles Boshra
Fathy Maklady
Chairperson
Helmy Bakr
Diabetes and thrombogenecity
Amal Rizk
Cairo
8:45 - 8:50
Discussion
8:50 - 9:05
Hyperglycemia in the acute phase of MI
9:05 - 9:20
Discussion
9:20 - 9:35
Antithrombotic treatment in diabetics with AMI
Mohamed Selim
9:35 - 9:40
Discussion
9:40 - 9:55
MI in diabetics; is it different?
Hisham Hegazy
9:55 - 10:00
Discussion
Suez Canal
92. Thursday, 27/Feb/2014
8:30
10:00
Hall:
Granite
Structural Heart Disease
STR-99
STR 6
New Insights into the management of PAD
Hamdy Soliman
Mesbah Taha Hassanein
Mohamed Omar El-Farouk
8:30 - 8:45
Essam Baligh
Magdy Gharib
Chairperson
Sanaa Abdel Shafy
PAD in the young (<40 years)
Raouf Mahran
NHI
8:45 - 8:48
Discussion
8:48 - 9:03
Current Medical Management of Claudication: How
Do Current Pharmacotherapies (PDEI) Work?
Ahmed El-Ghannam
NHI
9:03 - 9:06
Discussion
9:06 - 9:21
Gene and Cell Therapies for Claudication
Yasser Sadek
NHI
9:21 - 9:24
Discussion
9:24 - 9:39
Asymptomatic Severe Carotid Artery Stenosis
Hany Awadallah
9:39 - 9:42
Discussion
9:42 - 9:57
Challenging Endovascular Case
Walid Alami
9:57 - 10:00
Discussion
Ain Shams
93. Thursday, 27/Feb/2014
8:30
10:00
Hall:
Amber
Heart Rhythm
ECRA-100
Mini ECRA 7
Arrhythmia Management in Cardiac Emergency
Ahmed Abdel Gelil
Mazen Tawfik
Mohamed Hassan El-Rawy
8:30 - 8:42
Ahmed Abdel Aziz
Hassan Khaled
Chairperson
Rania Samir
Ventricular arrhythmia prophylaxis in acute MI
Moustafa Nawar
Alexandria
8:42 - 8:45
Discussion
8:45 - 8:57
Ablation outcome in scar related VT vs idiopathic VT
Tamer Fahmy
Cairo
8:57 - 9:00
Discussion
9:00 - 9:12
Implantable cardioverter-defibrillator implantation
after acute myocardial infarction, what did we learn?
Alaa Shalaby
USA
9:12 - 9:15
Discussion
9:15 - 9:27
Diagnosis and Management of Catecholaminergic
Ventricular Tachycardia in 2014
Marwan Refaat
Lebanon
9:27 - 9:30
Discussion
9:30 - 9:42
Early repolarization, when should I worry?
Hayam El-Damanhoury
9:42 - 9:45
Discussion
Ain Shams
94. Thursday, 27/Feb/2014
8:30
10:00
Hall:
Case Presentation
Cas -Pre-101
Worst Complications & Best Saves “Case Based”
Chairperson
8:30 - 8:42
Mohamed Abdel Ghani
Abrupt closure: dissection / thrombus
Ahmed Shawky
8:42 - 8:45
Discussion
8:45 - 8:57
Ain Shams
Case Presentation
Taymour Moustafa
8:57 - 9:00
Discussion
9:00 - 9:12
Case Presentation
Hossam El-Araby
9:12 - 9:15
Discussion
9:15 - 9:27
Assiut
Case Presentation
Bassem Abdel Hamid
9:27 - 9:30
Discussion
9:30 - 9:42
Military
Femoral complications
Khalid Tamam
9:42 - 9:45
Discussion
9:45 - 9:57
Case Presentation
9:57 - 10:00
Discussion
NHI
Turquoise
95. Thursday, 27/Feb/2014
10:00
11:30
Hall:
Blue Cany
Interventions
IHD-102
IHD 21
Radial Symposium
Hamdy Soliman
Hany Ragy
Hazem Warda
Hisham Boshra
Hossam Kandil
Chairperson
Mohamed Abdel Ghani
Sameh Shaheen
10:00 - 10:15
Step by step approach
Azeem Latib
Italy
10:15 - 10:18
Discussion
10:18 - 10:31
Dealing with Complex Arm and Chest Vasculature:
Strategies for Success
Stefan Hoffman
Germany
10:31 - 10:34
Discussion
10:34 - 10:49
Radial Artery Occlusion Prevention & Recanalization
Ahmed Rizk
Ain Shams
10:49 - 10:52
Discussion
10:52 - 11:07
Case presentation: Transradial complex PCI.
Sayed Abdo
11:07 - 11:10
Discussion
11:10 - 11:22
KSA
Transitioning to radial
Abdallah Shehab
11:22 - 11:25
Discussion
UAE
96. Thursday, 27/Feb/2014
10:00
11:30
Hall:
Rock Cany
Interventions
IHD-103
IHD 8
Stable Angina
Hisham Aboul Einen
Mohamed Lotfy
Reda El-Eisawy
10:00 - 10:15
Hazem El-Guindy
Mohamed Awad Taher
Chairperson
Yehia Kishk
Evidences and controversies in life style changes in
preventing CAD
Ayman Saleh
Ain Shams
10:15 - 10:18
Discussion
10:18 - 10:33
Why and when to revascularize in Stable CAD?
Gamal Aboul Nasr
NHI
10:33 - 10:36
Discussion
10:36 - 10:51
Oral Agents: Dabigatran, Rivaroxaban, Apixiban
Amin Fouad
Cairo
10:51 - 10:54
Discussion
10:54 - 11:09
How Do We Monitor the New Anticoagulant Agents?
Nerin Okasha
Ain Shams
11:09 - 11:12
Discussion
11:12 - 11:27
New concepts for screening asymptomatic diabetics
for IHD
Abdel Rahman Sharaf
11:27 - 11:30
Discussion
Al Azhar
97. Thursday, 27/Feb/2014
10:00
11:30
Hall:
Pearl I
Hypertension
HTN-104
HTN 3
Resistant Hypertension in 2014
Fathy Maklady
Mohamed Zaki
Soliman Gharib
10:00 - 10:15
Bassem Zarif
Mohamed Atef
Chairperson
Wagdy Ayad
Scope of the Problem and step by step approach
Karim Said
10:15 - 10:20
Discussion
10:20 - 10:35
Cairo
RDN; status in 2014
Adel El-Etriby
Ain Shams
10:35 - 10:40
Discussion
10:40 - 10:55
New drugs for resistant hypertension
Mahmoud Hassanein
10:55 - 11:00
Discussion
11:00 - 11:15
Alexandria
Other indications for denervation
Ahmed Abdel Aziz
11:15 - 11:20
Discussion
Cairo
98. Thursday, 27/Feb/2014
10:00
11:30
Hall:
Pearl II
Pediatric Cardiology
Ped-105
Ped 8
Grown-up with congenital Heart Disease “2”
Ayman Shoeib
Sahar El-Shedoudy
Tarek El-Walili
10:00 - 10:15
Alaa Roshdy
Maiy El-Sayed
Chairperson
Wahid Osman
Surgery in GUCH in Egypt; NHI experience
Sayed Salem
NHI
10:15 - 10:20
Discussion
10:20 - 10:35
Percutaneous placement of the melody valve in the
pulmonary position
Makram Ebeid
USA
10:35 - 10:40
Discussion
10:40 - 10:55
Management of complex congenital heart disease in
pregnancy
Ahmed Krimly
KSA
10:55 - 11:00
Discussion
11:00 - 11:15
Scoring system for congenital heart surgery; is it
useful to implement?
Sameh El-Amin
11:15 - 11:20
Discussion
99. Thursday, 27/Feb/2014
10:00
11:30
Hall:
Coral
Acute Cardiac Care
ACC-106
ACCC 7
Cardiovascular Emergencies during Pregnancy
Ayman Samir
Moustafa Mokarrab
Salwa Roshdy
10:00 - 10:15
Ali Abdallah
Magdy El-Khadem
Chairperson
Sanaa Ashour
Acute MI
Ragab Abdel Salam
10:15 - 10:18
Discussion
10:18 - 10:31
Zagazig
Peripartum Cardiomyopathy
Amr Youssef
Assiut
10:31 - 10:34
Discussion
10:34 - 10:51
Hypertensive Emergencies during Pregnancy
Mohamed Oraby
10:51 - 10:54
Discussion
10:54 - 11:09
Suez Canal
Arrhythmias during Pregnancy
Azza Katta
11:09 - 11:12
Discussion
11:12 - 11:27
NHI
DVT, PE during pregnancy
Ahmed Ghali
11:27 - 11:30
Discussion
Ain Shams
100. Thursday, 27/Feb/2014
10:00
11:30
Hall:
Granite
Structural Heart Disease
STR-107
STR 7
Thoracoabdominal aorta; all what you need to know
Khaled Leon
Nabil Farag
Raouf Mahran
Chairperson
Taher El-Kady
Tarek Naguib
10:00 - 10:15
10:15 - 10:18
10:18 - 10:33
10:33 - 10:36
10:36 - 10:51
10:51 - 10:54
10:54 - 11:09
11:09 - 11:12
11:12 - 11:27
11:27 - 11:30
Thoracic Aortic Syndromes; magnitude of the
problem
Mohamed El-Maraghy
NHI
Discussion
Technological Advances in Aortic Imaging
Fabiola Sozzi
Italy
Discussion
Endovascular and Stent-Graft Treatment of Aortic
Dissection
Sherif Essam
Ain Shams
Discussion
Surgical and Hybrid Approaches to Thoracic Aortic
Disease
Ahmed El-Kirdany
Ain Shams
Discussion
Endovascular Repair of Thoracoabdominal
Aneurysms
Mohamed Hosny
Cairo
Discussion
101. Thursday, 27/Feb/2014
10:00
11:30
Hall:
Amber
Heart Rhythm
ECRA-108
Mini ECRA 6
The Truth about CRT
Doaa Fouad
Hisham El-Aasar
Mervat Aboul Maaty
10:00 - 10:12
Amr El-Hadidy
Hatem Kholeif
Chairperson
Tamer Fahmy
Indications and patient assessment
Rania Samir
Ain Shams
10:12 - 10:15
Discussion
10:15 - 10:27
What have we learnt from clinical trials?
Sherif Mokhtar
10:27 - 10:30
Discussion
10:30 - 10:42
How can CRT improve my patient?
10:42 - 10:45
Discussion
10:45 - 10:57
Cairo
CRT/ ICD what have we achieved?
Ahmed Osman
USA
10:57 - 11:00
Discussion
11:00 - 11:12
Tips and tricks, practical issues
11:12 - 11:15
Discussion
11:15 - 11:27
Device Therapy; CRT – when and why?
Amr Kamal
11:27 - 11:30
Discussion
Alexandria
102. Thursday, 27/Feb/2014
10:00
Hall:
Turquoise
Hall:
11:30
Blue Cany
EuroPCR
EuroPCR-109
EuroPCR
EuroPCR
Thursday, 27/Feb/2014
12:00
13:00
Company Symposium
Comp Symp-110
Sanofi Symposium
12:00 - 12:35
Ahmed Magdy
Mohamed Sobhy
Sherif El-Tobgy
Chairperson
Sherif Wagdy Ayad
Blood Thinners: Efficacy/Safety/Cost Effectiveness
Hany Ragy
NHI
Adel El-Etriby
Ain Shams
12:35 - 12:40
Discussion
12:40 - 12:55
High risk hypertensive patients: Can we do better?
Sameh Shaheen
12:55 - 13:00
Discussion
Ain Shams